ArticleCureus2025
Well-Differentiated Spindle Cell Liposarcoma of the Larynx in a Patient With a History of a Benign Laryngeal Lesion: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liposarcomas of the larynx are an extremely rare occurrence. Though they are malignant, their presentation in the larynx may mimic benign conditions; therefore, diagnosis requires histologic evaluation. Our case represents the second known case of laryngeal well-differentiated spindle cell liposarcoma. The patient, a 74-year-old man, presented with dysphagia for two months with a history of a benign laryngeal lesion removed many years prior at another facility. His examination and operative evaluation were initially consistent with a recurrent internal laryngocele, but after pathologic evaluation, the diagnosis of well-differentiated spindle cell liposarcoma was made based on the histologic features as well as cluster of differentiation 34 (CD34) positivity, amplification of murine double minute-2 (MDM2) by fluorescence in situ hybridization (FISH), retained retinoblastoma (RB) protein expression, and negativity for signal transducer and activator of transcription 6 (STAT6). Treatment of these masses typically involves wide local excision, and because they have high rates of recurrence, postoperative surveillance is necessary as well. From this case, it can be concluded that liposarcomas of the larynx should be part of the differential diagnosis of laryngeal masses, even when they appear benign. Due to their rarity, research for risk factors as well as the prognosis of laryngeal liposarcomas is limited, and further studies are needed to better understand these topics and how they affect the diagnosis and treatment of laryngeal liposarcomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.